0.2760
-0.0360
(-11.54%)
As of January 28 at 8:07:01 AM GMT+1. Market Open.
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Operating Cash Flow
-23,475.9590
-24,126.1280
-23,744.8600
-12,484.3760
-7,750.1880
Investing Cash Flow
-756.8010
-681.8010
--
--
--
Financing Cash Flow
16,379.1780
4,418.9260
3,954.3000
-3,742.6570
64,997.6240
End Cash Position
5,792.2650
862.0890
21,251.0920
41,041.6520
57,268.6850
Capital Expenditure
--
-456.8010
--
--
--
Issuance of Capital Stock
16,085.9270
4,418.9260
4,000.0000
--
51,622.3370
Issuance of Debt
--
--
--
--
215.7100
Repayment of Debt
--
--
--
--
-546.1080
Repurchase of Capital Stock
--
--
-47.2940
-10,171.7320
--
Free Cash Flow
-23,932.7600
-24,582.9290
-23,744.8600
-12,484.3760
-7,750.1880
7/31/2021 - 9/5/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RLFTY Relief Therapeutics Holding SA
4.4000
0.00%
LEXX Lexaria Bioscience Corp.
1.8200
+0.55%
HOPHF Hemogenyx Pharmaceuticals Plc
1.2400
0.00%
AEON AEON Biopharma, Inc.
0.1215
+1.25%
AZTR Azitra, Inc.
0.2522
+1.00%
CNSP CNS Pharmaceuticals, Inc.
0.0998
-0.60%
CADL Candel Therapeutics, Inc.
6.96
+4.82%
PHIO Phio Pharmaceuticals Corp.
2.2200
-2.63%
SLS SELLAS Life Sciences Group, Inc.
1.3300
+9.02%
DWTX Dogwood Therapeutics, Inc.
12.76
+6.24%